Search

Your search keyword '"Hani Gabra"' showing total 346 results

Search Constraints

Start Over You searched for: Author "Hani Gabra" Remove constraint Author: "Hani Gabra"
346 results on '"Hani Gabra"'

Search Results

1. The association between obesity and weight loss after bariatric surgery on the vaginal microbiota

2. Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma

3. Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions

4. A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer

5. 362 A PhII study of bemcentinib, a first-in-class selective AXL kinase inhibitor, in combination with pembrolizumab in pts with previously-treated advanced NSCLC: Updated clinical & translational analysis

6. Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients

7. Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer

8. Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer

9. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

10. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

11. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

12. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

13. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

14. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

15. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

16. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

17. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

18. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

19. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

20. Introduction to managing patients with recurrent ovarian cancer

21. DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance

22. Foreword

23. Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer

25. Supplementary Figure 1 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

26. Data from The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer

28. Supplementary Figure 8 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

29. Supplementary Figure 3 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

30. Supplementary Table 2 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

31. Supplementary Figure 4 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

32. Supplementary Table 1 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

33. Supplementary Figure 2 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

34. Supplementary Figure 7 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

35. Supplementary Figure 6 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

37. Supplementary Figure 5 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

38. Interview with Dr. Gabra from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

39. Supplementary Figure Legends 1-9 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

40. Data from Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy

41. Supplementary Figure 9 from The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

42. Supplemental Figures 1-3 and Supplemental Tables 1-9 from Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy

45. Supplementary Figure S3 from A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

46. Data from A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer

47. Data from PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

48. Supplementary Figures S1-S11 from Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer

49. Data from A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

50. Supplementary Data from Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas

Catalog

Books, media, physical & digital resources